In the Research Article “mTORC1 Inhibition Is Required for Sensitivity to PI3K p110α Inhibitors in PIK3CA-Mutant Breast Cancer,” the authors have provided additional competing interests upon request by the editors, and the competing interests statements have been updated. The PDF and HTML (full text) have been corrected.
- Copyright © 2018, American Association for the Advancement of Science